EN PL
CASE REPORT
Osteo-articular manifestation of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)
 
More details
Hide details
 
Online publication date: 2011-08-30
 
 
Reumatologia 2011;49(4):288-293
 
KEYWORDS
ABSTRACT
Authors present a case of 38-year-old woman, of whom the first symptoms of the disease were poor exercise tolerance, increasing limitation of motion in the shoulder, elbow and hip joints and bone pain. At the age of 37, the patient presented rapid cardiac symptoms (significantly decreased physical activity tolerance, dyspnea, generalized fatigue). A typical result of heart ultrasound examination together with radiologic features (dysostosis multiplex) suggested mucopolysaccharidosis. Mucopolysaccharidosis type VI (MPS VI) was confirmed by a screening test which revealed the presence of dermatan sulphate and enzyme assay with significantly decreased activity of arylsulfatase B (ARSB). The patient represents relatively attenuated MPS VI with osteo-articular and cardiac changes (Table I, II, Figure 1, 2).
REFERENCES (20)
1.
Neufeld EF, Muenzer J. The Mucopolysaccharidoses. In: Valle D, Beaudet AL, Vogelstein B, et al. (eds.). The Online Metabolic and Molecular Bases of Inherited Disease; www.ommbid.com. .
 
2.
Maroteaux P, Leveque B, Marie J, Lamy M. A new dysostosis with urinary elimination of chondroitin sulfate B. Presse Med 1963; 71: 1849-1852.  .
 
3.
Jurecka A, Różdżyńska A, Marucha J i wsp. Choroba Maroteaux-Lamy’ego (mukopolisacharydoza typu VI): obraz kliniczny, diagnostyka i leczenie. Pediatr Pol 2010; 85: 305-310. .
 
4.
Jurecka A, Różdżyńska A, Marucha J i wsp. Polscy pacjenci z chorobą Maroteaux-Lamy’ego (mukopolisacharydozą typu VI). Pediatr Pol 2010; 85: 311-319. .
 
5.
Juecka A, Marucha J, Różdżyńska A i wsp. Przypadek mukopolisacharydozy typu VI (choroby Maroteaux-Lamy’ego) – charakterystyka kliniczna. Pediatr Pol 2010; 85: 399-406. .
 
6.
Jurecka A, Różdżyńska A, Marucha J i wsp. Mukopolisacharydoza typu VI (choroba Maroteaux-Lamy’ego) – opis przypadku. Nowa Pediatria 2010; 2: 67-72. .
 
7.
Jurecka A, Różdżyńska A, Marucha J i wsp. Mukopolisacharydoza typu VI (choroba Maroteaux-Lamy’ego) – opis przypadku. Pediatr Med Rodz 2010; 6: 151-155. .
 
8.
Cieślik J, Kaczmarek M, Kaliszewska-Drozdowska MD. Dziecko poznańskie’90. Wzrastanie, dojrzewanie, normy i metody rozwoju. Wydawnictwo Naukowe Bogucki, Poznań 1994. .
 
9.
Palczewska I, Niedźwiedzka Z. Wskaźniki rozwoju somatycznego dzieci i młodzieży warszawskiej. Medycyna Wieku Rozwojowego 2001; 2 Supl. 1: 17-23. .
 
10.
Gerhardt JJ. Clinical measurements of joint motion and position in the neutral-zero method and SFTR recording: basic principles. Int Rehabil Med 1983; 5: 161-164. .
 
11.
Zembaty A. Kinezyterapia. Tom 1. Wydawnictwo Kasper, Kraków 2002; 62-73, 239-243. .
 
12.
Tan CT, Schaff HV, Miller FA Jr, et al. Valvular heart disease in four patients with Maroteaux-Lamy syndrome. Circulation 1992; 85: 188-195. .
 
13.
Wippermann CF, Beck M, Schranz D, et al. Mitral and aortic regurgitation in 84 patients with with mucopolysaccharidoses. Eur J Pediatr 1995; 154: 98-101. .
 
14.
Miller G, Partridge A. Mucopolysaccharidosis type VI presenting in infancy with endocardial fibroelastosis and heart failure. Pediatr Cardiol 1983; 4: 61-62. .
 
15.
Tylki-Szymanska A, Rozdzynska A, Jurecka A, et al. Anthropometric data of 14 patients with mucopolysaccharidosis I: restrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase). Mol Genet Metab 2010; 99: 10-17. .
 
16.
Cimaz R, Coppa GV, Koné-Paut I, et al. Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J 2009; 7: 18. .
 
17.
Simonaro CM, D'Angelo M, He X, et al. Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol 2008; 172: 112-122. .
 
18.
Simonaro CM, Haskins ME, Schuchman EH. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Invest 2001; 81: 1319-1328. .
 
19.
Valayannopoulos V, Nicely H, Harmatz P, Turbeville S. Mucopolysaccharidosis VI. Orphanet J Rare Dis 2010; 5: 5. .
 
20.
Michels H, Mengel E. Lysosomal storage diseases as differential diagnoses to rheumatic disorders. Curr Opin Rheumatol 2008; 20: 76-81.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top